We are live on ! Find out more
RCG

Ruane, Cunniff & Goldfarb Portfolio holdings

AUM $6.03B
1-Year Est. Return 12.06%
This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+12.06%
3 Year Est. Return
+70.12%
5 Year Est. Return
+58.04%
10 Year Est. Return
+390.27%
AUM
$21B
AUM Growth
-$152M
Cap. Flow
-$684M
Cap. Flow %
-3.26%
Top 10 Hldgs %
73.97%
Holding
158
New
3
Increased
19
Reduced
52
Closed
10

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$110M
2
MMYT icon
MakeMyTrip
MMYT
+$24.2M
3
SPNT icon
SiriusPoint
SPNT
+$20.8M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.7M
5
YELP icon
Yelp
YELP
+$5M

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$565M
2
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
+$52.3M
3
BHC icon
Bausch Health
BHC
+$45.5M
4
PRGO icon
Perrigo
PRGO
+$44.2M
5
PRI icon
Primerica
PRI
+$34.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.83%
2 Financials 19.3%
3 Consumer Discretionary 12.32%
4 Industrials 10.19%
5 Communication Services 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROW icon
126
T. Rowe Price
TROW
$26.1B
$314K ﹤0.01%
4,045
– –
MMM icon
127
3M
MMM
$94.1B
$312K ﹤0.01%
2,417
– –
EMR icon
128
Emerson Electric
EMR
$85B
$279K ﹤0.01%
5,035
– –
MRK icon
129
Merck
MRK
$326B
$272K ﹤0.01%
5,014
– –
AMAT icon
130
Applied Materials
AMAT
$378B
$263K ﹤0.01%
13,692
– –
EBAY icon
131
eBay
EBAY
$52.1B
$254K ﹤0.01%
10,027
– –
TECH icon
132
Bio-Techne
TECH
$11.2B
$250K ﹤0.01%
10,160
– –
AMGN icon
133
Amgen
AMGN
$212B
$248K ﹤0.01%
1,617
– –
BA icon
134
Boeing
BA
$175B
$248K ﹤0.01%
1,790
– –
BMY icon
135
Bristol-Myers Squibb
BMY
$130B
$244K ﹤0.01%
3,670
– –
BP icon
136
BP
BP
$107B
$238K ﹤0.01%
7,069
-100
-1% -$3.5K
CL icon
137
Colgate-Palmolive
CL
$74.2B
$232K ﹤0.01%
3,548
– –
INDY icon
138
iShares S&P India Nifty 50 Index Fund
INDY
$560M
$229K ﹤0.01%
7,674
– –
T icon
139
AT&T
T
$169B
$216K ﹤0.01%
+8,055
New +$208K
CB
140
DELISTED
CHUBB CORPORATION
CB
$211K ﹤0.01%
2,222
-1,200
-35% -$118K
RTX icon
141
RTX Corp
RTX
$295B
$208K ﹤0.01%
2,976
– –
EPC icon
142
Edgewell Personal Care
EPC
$1.3B
$202K ﹤0.01%
1,535
-584
-28% -$60.3K
CTSH icon
143
Cognizant
CTSH
$23.8B
$200K ﹤0.01%
3,279
– –
BLK icon
144
Blackrock
BLK
$170B
– –
-550
Closed -$201K
DUK icon
145
Duke Energy
DUK
$101B
– –
-2,640
Closed -$203K
DVN icon
146
Devon Energy
DVN
$49.2B
– –
-3,340
Closed -$201K
GIS icon
147
General Mills
GIS
$20.1B
– –
-20,567
Closed -$1.16M
INTC icon
148
Intel
INTC
$435B
– –
-7,311
Closed -$229K
ITUB icon
149
Itaú Unibanco
ITUB
$91.6B
– –
-35,578
Closed -$158K
SEIC icon
150
SEI Investments
SEIC
$12.4B
– –
-10,000
Closed -$441K
3 4 5
6
7

Similar funds

WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
GFM
GF Fund Management Guangzhou, China $5.98B AUM 80.99% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's Q2 2015 Portfolio in Review

As of Q2 2015, Ruane, Cunniff & Goldfarb held 158 positions worth $21B, down 0.72% from $21.1B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Ruane, Cunniff & Goldfarb withdrew a net $684M in Q2 2015, closing 10 positions and reducing 52 holdings. Its most notable exit was SALIX PHARMACEUTICALS LTD DEL, an estimated $3.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 40% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Ruane, Cunniff & Goldfarb opened a new position in Yelp worth $4.63M.

  • Ruane, Cunniff & Goldfarb's largest Q2 2015 buy was Yelp: 107,700 shares worth $4.63M.
  • Ruane, Cunniff & Goldfarb added most to Monsanto Co in Q2 2015, an estimated $110M increase.
  • Ruane, Cunniff & Goldfarb's biggest Q2 2015 reduction was TJX Companies, cutting an estimated $565M.
  • Ruane, Cunniff & Goldfarb fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $3.46M.
  • Ruane, Cunniff & Goldfarb's ten largest holdings make up 74% of its $21B portfolio in Q2 2015.
  • Ruane, Cunniff & Goldfarb opened 3 new positions and closed 10 in Q2 2015.
  • Ruane, Cunniff & Goldfarb's portfolio value fell 0.72% quarter-over-quarter to $21B.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2015, filed 14 Aug 2015.